Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia

This study protocol evaluates the use of hysteroscopic endomyometrial resection in women diagnosed with atypical endometrial hyperplasia or grade I endometrial cancer who have not responded to anti-hormone therapy. Patients in this study wish to preserve fertility.

Trial Details

NCT ID
NCT04362046
Phase
NA
Sponsor
Vancouver Coastal Health Research Institute
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • Hysteroscopic uterine resection
Locations (sample)
  • Vancouver, British Columbia, Canada|49.24966,-123.11934

Key Eligibility Criteria

  • Age less than 40 years
  • Pathologist confirmed biopsy evidence of one of the following:
  • Grade I endometrial endometrioid adrenocarcinoma (EC) with less than 1/3 of the endometrial surface involved.
  • Atypical endometrial hyperplasia (AH)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →